. . . . . . . . . . . . "a(CHEBI:ceramide) -| r(RGD:Cyp2b1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Ceramide formation reached a maximum 3 h after DHA administration. C2-ceramide dose-dependently inhibited PB-induced CYP 2B1 expression and increased intracellular cAMP concentrations. " . . "Selventa" . . . . "2014-07-03T14:33:34.720+02:00"^^ . . .